Mixing insulin analogs for Type 1 kids is safe, say researchers

We’re usually told it’s a big health and safety no-no to mix ‘n’ match medications, right? Well, here’s an exception that affects diabetics. Apparently, youngsters with Type 1 diabetes and their parents/caregivers can safely mix rapid-acting and long-acting insulin analogs in the same syringe. The results of a new study published in the Journal of Pediatrics (April 2006) show that doing so does not compromise blood sugar stability in the long-term.

Examples of rapid-acting insulin analogues are Apridra and NovoRapid. Lantus is an examples of a long-acting insulin glargine. For some kids, mixing the two together could potentially reduce the number of insulin shots required daily. This is always good news for children and their parents.

Print Version
Tell-a-Friend

RELATED ARTICLES:

Class of Diabetes Drugs Carries Significant Cardiovascular Risks   Potential diabetes treatment selectively kills autoimmune cells from human patients   Low cholesterol associated with cancer in diabetics   Arsenic Exposure May Be Associated With Type 2 Diabetes   Gum disease tied to diabetes risk   Cultural sensitivity may improve diabetes outcomes   Diabetic foot ulcers often have poor outcomes   Men may need to work harder to cut diabetes risk   Diabetes makes people more vulnerable to TB: study   Many Hispanics with diabetes unaware of potential eye disease, do not receive eye exams   Heart disease and diabetes: Which statins have been well-investigated?   Type 2 diabetes epidemic seen looming